The outlook of companies tied to flagship drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the expiry in key regions has introduced considerable volatility. Investors are now grappling with the impact of generic competition , dimi